Pain Injection Versus Epidural Anesthesia for Hip Surgery in Pediatric Patients With Cerebral Palsy
Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Dec 30, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to manage pain after hip surgery in children with cerebral palsy (CP). The researchers want to compare two methods: a special pain injection at the surgery site and traditional epidural anesthesia. Epidural anesthesia is commonly used but can have risks, especially in children with CP who may have other health issues. The trial aims to see if the new pain injection can control pain just as well or better than epidural anesthesia, while potentially having fewer side effects.
To participate in this study, children must be under 18 years old and have a diagnosis of cerebral palsy or a similar condition. They should be scheduled for a specific type of hip surgery called a proximal femoral osteotomy. Participants will be monitored during and after surgery to assess their pain levels and how well each method works. If you’re considering this trial for your child, it could offer them a chance to experience safer and more effective pain management after their surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • under 18 years old
- • diagnosis of cerebral palsy or similar neuromuscular disease
- • undergoing uni- or bilateral proximal femoral osteotomy
- Exclusion Criteria:
- • ongoing preoperative opioid use
- • history of allergic reaction to any component of the pain injection
- • history of adverse reaction to epidural anesthesia
About University Of California, Los Angeles
The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Los Angeles, California, United States
Santa Monica, California, United States
Los Angeles, California, United States
Patients applied
Trial Officials
Rachel M Thompson, MD
Principal Investigator
University of California, Los Angeles
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported